| Leman Olson, RPH | |
|
910 N Eisenhower Ave, Mason City, IA 50401-1525 | |
| (641) 422-7917 | |
| Not Available |
| Full Name | Leman Olson |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 910 N Eisenhower Ave, Mason City, Iowa |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033241914 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 13510 (Iowa) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Leman Olson, RPH 910 N Eisenhower Ave, Mason City, IA 50401-1525 Ph: (641) 422-7917 | Leman Olson, RPH 910 N Eisenhower Ave, Mason City, IA 50401-1525 Ph: (641) 422-7917 |
News Archive
Late-breaking results from the ElectroCRT trial presented today at EHRA 2019 a European Society of Cardiology congress, pave the way for a new standard of care to improve the heart's pump function in selected patients with heart failure.
WuXi NextCODE, a precision medicine company using the genome to improve health worldwide, and Sidra Medical and Research Center, a groundbreaking hospital, research and education institution, today announced a broad, long-term agreement to provide and co-develop comprehensive research and bioinformatics programs.
In a recent study posted to the medRxiv preprint server, a research group from Italy has demonstrated that the antibody response can be blunted in subjects with certain risk factors shortly after the second dose of mRNA vaccine against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
NovAlix today announces that it has entered into a multi-year research services agreement for chemistry with Janssen-Cilag, France, to support its drug discovery efforts.
Following two decades of research on a group of rare diseases called hypereosinophilic syndrome at Cincinnati Children's Hospital Medical Center, the U.S. Food and Drug Administration has approved the drug Nucala (mepolizumab) for use in the treatment of patients with hypereosinophilic syndrome.
› Verified 3 days ago
Laura Spicer, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1010 4th St Sw, Mason City, IA 50401 Phone: 641-422-6105 Fax: 641-422-6107 | |
Dr. Daniel Carroll Wahl, PHARM. D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3450 4th St Sw, T-0804, Mason City, IA 50401 Phone: 641-423-1325 | |
Sungha Kim, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1000 4th St Sw, Mason City, IA 50401 Phone: 641-428-7600 | |
Lisa Jean Hubka, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1251 4th St Sw, Mason City, IA 50401 Phone: 641-423-2034 Fax: 641-423-0527 | |
Jade Engstler, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1251 4th St Sw, Mason City, IA 50401 Phone: 641-423-2035 | |
Dr. Mary Jill Leisure, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1000 4th St Sw, Mason City, IA 50401 Phone: 641-424-6847 Fax: 641-424-6876 |